Categories: News

Edison Issues Report on Metro Bank (MTRO)

London, United Kingdom–(Newsfile Corp. – October 31, 2024) – Edison issues report on Metro Bank (LSE: MTRO).

Having successfully refinanced in late 2023, Metro Bank is making good progress with repositioning its business model towards higher-return commercial and specialist mortgage lending, reducing its cost of funding and shrinking its cost base. It confidently expects to be profitable before year-end and has guided to strong progress thereafter, reaching a mid- to upper-teens percentage return on tangible equity from 2027. Despite a strong performance since the interims, Metro’s shares are far from pricing in the scale of improvement that management is guiding towards.

Click here to read the full report.

All reports published by Edison are available to download free of charge from its website www.edisongroup.com.

Edison is authorised and regulated by the Financial Conduct Authority.

Edison is not an adviser or broker-dealer and does not provide investment advice. Edison’s reports are not solicitations to buy or sell any securities.

For more information, please contact Edison:

enquiries@edisongroup.com

+44 (0)20 3077 5700

Connect with Edison on:

LinkedIn www.linkedin.com/company/edison-group-/
X www.x.com/edison_inv_res
YouTube www.youtube.com/edisonitv

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/228464

Staff

Recent Posts

Altamira Therapeutics Announces Market Approval of Bentrio Nasal Spray in China

Regulatory clearance of Bentrio in allergic rhinitis for Mainland ChinaNearly 200 million Chinese estimated to…

2 hours ago

Cosmos Health is Forcing the Market to Reframe the Conversation

CHICAGO, IL / ACCESS Newswire / December 19, 2025 / For a long stretch, Cosmos…

2 hours ago

Remedy’s Nutrition® Launches Mega VMT™ High-Potency Multivitamin to Revolutionize Daily Energy and Nutritional Wellness

KEY LARGO, Fla., Dec. 19, 2025 (GLOBE NEWSWIRE) -- Remedy's Nutrition®, a trusted natural dietary…

2 hours ago

Profound Medical Corp. Announces Pricing of up to $40 Million Financing Comprised of a $36 Million Registered Direct Offering and a Subsequent $4 Million Private Placement

Financing included participation by healthcare-dedicated investors alongside existing shareholdersTORONTO, Dec. 19, 2025 (GLOBE NEWSWIRE) --…

2 hours ago